Paediatrician in London

Rare Diseases in Children: Could AI Help Diagnose Them Earlier?

When your child has unusual symptoms, you may find getting the right diagnosis takes time. You may see several specialists investigate different problems before your child’s condition is recognised, creating what is often called a diagnostic odyssey.

For some children with a suspected genetic condition, genomic testing can help shorten this journey, and you may also see AI used to spot patterns across your child’s symptoms, records and test results. AI should not be used to diagnose your child on its own, but it may help their doctors identify possible conditions earlier and decide which further tests are needed.

Why Can Rare Diseases Take So Long to Diagnose?

Rare diseases can be difficult to diagnose because your child’s symptoms may look like common conditions. You may see tiredness, seizures, delayed development or feeding problems, but the real clue can be the combination of several features.

Your child’s symptoms can also change with age, making the overall pattern harder for their doctors to recognise. AI may help by comparing your child’s symptoms with thousands of disease patterns and highlighting additional possibilities for their specialists to investigate.

What Should You Understand by “AI Diagnosis”?

If AI is mentioned during your child’s assessment, you should know that it does not mean a computer is making the final diagnosis. You may see different AI tools analyse your child’s symptoms, medical records, genetic results or medical images and suggest conditions that could be worth investigating.

You should treat these suggestions as decision support rather than answers. Your child’s doctors still need to decide whether a suggested condition fits the clinical picture, and you can ask what evidence supports it, which tests would confirm it and how much confidence you should place in the AI result.

UK Guidance Note

If your child is being investigated for a suspected rare genetic condition in England, genomic testing may be available through NHS genomic pathways when the relevant eligibility criteria are met. The England Rare Diseases Action Plan 2026 prioritises faster diagnosis and advanced genomic approaches, but AI suggestions should still be interpreted within specialist clinical and genomic services rather than treated as standalone diagnoses. The AI systems discussed in this article have mainly been evaluated in research studies, so you should not assume that tools such as PhenoBrain, DeepRare or Eye2Gene are routinely available through the NHS.

What New NHS Services Could Help Your Child?

Clinician showing a laptop to a mother and daughter

If your child remains undiagnosed after specialist assessment, you may hear about new NHS pathways for particularly difficult rare-disease cases. The England Rare Diseases Action Plan 2026 says two pilot centres are expected to become operational by autumn 2026 for children and adults whose condition may have a genetic cause or where further genomic investigation could help.

You should not assume that every child with unexplained symptoms will need these advanced services. If your child’s team thinks a referral could be relevant, you can ask what additional testing may be considered and what you should expect from technologies such as advanced genomics, multiomics or functional genomics.

How Could AI Recognise Patterns in Your Child’s Symptoms?

If your child has several unusual features, you may describe them differently at different appointments. You should know that AI tools can help organise details such as seizures, delayed development, short stature or hearing problems and translate them into standardised medical terms that specialists can compare more consistently.

Using vocabularies such as the Human Phenotype Ontology, AI can compare your child’s combination of features with known rare-disease patterns. You should not treat that comparison as a diagnosis, but you can use it with your child’s doctors to understand which conditions may deserve further investigation and what testing you may need next.

Could AI Find a Pattern in Your Child’s Medical Records?

If your child has seen several specialists over time, you may find that important clues are spread across different records. You may not realise that symptoms, test results and earlier appointments could be connected, so AI may help your child’s doctors bring those details together.

You should still expect a specialist to review any pattern the system identifies. You can ask what evidence supports the connection and what you still need to confirm before it affects your child’s diagnosis.

Evidence Note

In a 2025 study involving 75 clinical cases, a simulated combination of specialist physicians’ diagnoses and PhenoBrain predictions achieved a top-three recall of 76.8%. The important point is that AI appeared most useful when combined with medical expertise rather than used as a replacement for specialist judgement.

How Could AI Help Interpret Your Child’s Genomic Testing?

If your child has whole genome or other genomic testing, you may be surprised by how many genetic differences are found. Most are harmless, so you should know that AI can help your child’s clinical team prioritise variants that appear more consistent with the symptoms, inheritance pattern and other medical evidence.

You should not assume that a highly ranked variant automatically explains your child’s condition. You can ask which genetic findings are considered important, what supporting evidence is available and whether you need further testing before a diagnosis can be confirmed.

Research Insight

In the 2026 DeepRare study, combining genetic information with clinical features improved how often the correct diagnosis was ranked first in two research datasets. The important point is that combining clinical and genetic information may strengthen AI-assisted diagnosis, although these findings still require specialist interpretation before they can guide clinical care.

Why Might Your Child Still Be Undiagnosed After Whole Genome Sequencing?

Doctor showing results on a monitor to a girl

Whole genome sequencing can give your child’s doctors millions of genetic differences, but most are harmless or uncertain. You may therefore find that sequencing is only the start, as AI can help prioritise variants while your child’s specialist team still needs to interpret them.

Some disease-causing genes or genetic changes are not yet fully understood, which can leave your child without a clear diagnosis. AI cannot turn an uncertain genetic finding into a confirmed diagnosis without sufficient supporting evidence, so further testing or review may still be needed.

Could AI Reanalyse Your Child’s Genome Years Later?

A genetic result that was unclear when your child was tested may become meaningful as researchers discover new gene-disease links. You may therefore benefit from reanalysing your child’s existing data, even though your child’s DNA itself has not changed.

AI could help your child’s doctors match older genomic results with newly discovered gene-disease links. A 2026 retrospective study found that AI-assisted reanalysis produced additional diagnoses in previously unsolved cohorts, but expert review and clinical confirmation were still required before findings were returned as diagnoses.

Clinical Tip

If your child previously had genomic testing without receiving a diagnosis, you can ask their clinical genetics team whether reanalysis may be appropriate as medical knowledge develops. You should avoid uploading your child’s identifiable health records, photographs or genomic data to public AI tools unless appropriate privacy, consent and clinical safeguards are in place.

How Could AI Support Different Parts of Rare Disease Diagnosis?

Area of assessmentHow AI may helpWhat still needs specialist review
Symptoms and phenotypingAI can organise your child’s clinical features and compare patterns with known rare diseases.Doctors still need to confirm whether the suggested features accurately describe your child.
Medical recordsAI may identify connections across previous appointments, investigations and specialist notes.Your child’s clinical team must check whether the suggested pattern is medically meaningful.
Genomic testingAI can help prioritise genetic variants that may fit your child’s symptoms and inheritance pattern.Clinical geneticists and laboratory specialists still need to interpret and confirm relevant findings.
Medical imagingSome AI tools can identify patterns in specialised images, such as retinal scans.Imaging findings need to be reviewed alongside your child’s examination, symptoms and other test results.
Genome reanalysisAI may help match older genomic results with newly discovered gene-disease links.Any new finding still requires expert review and appropriate clinical confirmation.

Could AI Analyse Your Child’s Medical Images?

AI can analyse medical images and identify patterns that may be difficult to describe in words. You may see this used with retinal scans, where AI can help your child’s doctors identify genes that could explain an unusual eye pattern.

A 2025 Eye2Gene study found that the correct gene appeared among the system’s top five suggestions in 83.9% of test cases. Eye2Gene was developed specifically for inherited retinal diseases, so its results should not be generalised to rare diseases more broadly and still require specialist interpretation alongside genetic and clinical evidence.

Could AI Analyse Your Child’s Facial Features?

Doctor showing a laptop to a mother and daughter

Some genetic conditions can cause distinctive facial features, and AI can analyse these patterns from photographs. You may see this help your child’s geneticist consider possible conditions, but you should never treat an AI facial score as your child’s diagnosis.

Facial features vary with age, ancestry and normal family characteristics, which can affect how these tools perform. Privacy, consent, data security and potential bias also need careful consideration before facial images are used for AI-assisted genetic assessment.

Could AI Help Diagnose Your Child Before a Rare Disease Becomes Obvious?

AI could help your child’s doctors connect mild symptoms across different appointments and identify patterns that may suggest a rare disease. Earlier recognition may allow your child to receive appropriate specialist assessment, monitoring or treatment sooner where relevant.

AI alerts can still be wrong, so you should expect clinical confirmation before any result affects your child’s treatment.

Why Shouldn’t AI Make Your Child’s Final Diagnosis?

AI can spot patterns in your child’s symptoms, but diagnosis involves much more than identifying similarities. Your paediatrician, geneticist and other specialists still need to check your child’s history, genetic results, examinations and laboratory tests.

Rare conditions can involve unusual genetic variants or, in some cases, more than one diagnosis, so specialist clinical judgement remains essential.

What Should You Know About the Risks of AI-Assisted Diagnosis?

AI can help your child’s doctors identify patterns that may otherwise be difficult to recognise, but it can also make mistakes. The quality of its suggestions depends on the information it receives, the evidence it has been trained on and how carefully the results are reviewed by specialists.

  • Incomplete Records Can Affect Results: If important symptoms, test results or medical history are missing, AI may suggest conditions that do not fit your child accurately.
  • Symptoms Can Be Misinterpreted: If your child’s features are described incorrectly or translated into the wrong clinical terms, the system may rank inappropriate conditions.
  • AI Can Produce Unsupported Suggestions: Some systems may generate convincing-looking explanations that are not supported by enough medical evidence.
  • Clinical Review Is Still Essential: Your child’s doctors must compare any AI suggestion with examinations, genetic findings and other test results before reaching a diagnosis.

You should still treat AI as a support tool, with any suggested diagnosis confirmed by your child’s specialist team.

Could AI Be Less Accurate for Your Child?

Yes. AI may be less reliable for your child if children with a similar age, ancestry, clinical presentation or rare condition were under-represented in the data used to develop and test the system. Clinicians should therefore consider how well a tool has been validated in populations that are relevant to your child.

You should therefore ask whether the AI tool has been tested in children with a similar background and condition to your child.

When Might Your Child Need Assessment for a Rare Disease?

Clinician talking with a father and daughter

Most children with common symptoms do not have a rare disease, but you may need further assessment if your child has several unusual or persistent features. You may notice developmental differences, unexplained growth problems, problems affecting different organs or a family history of similar unexplained symptoms or conditions.

You should speak to your child’s healthcare professional if these features persist or seem unusual, so they can decide whether specialist testing may be appropriate.

Myth vs Fact

MythFact
AI can diagnose your child’s rare disease from their symptoms alone.AI can rank possible conditions, but your child still needs clinical assessment and appropriate testing to confirm a diagnosis.
Whole genome sequencing automatically gives your child a diagnosis.Sequencing identifies many genetic variants, and specialist interpretation is needed to determine whether any explain your child’s condition.
If an AI system ranks one condition first, your child definitely has it.A high-ranking suggestion is only a possibility for investigation and can still be incorrect.
An inconclusive genomic result means nothing more can be learned later.New gene-disease discoveries may allow your child’s existing genomic data to be reanalysed in the future.
AI gives equally accurate results for every child.Performance may vary according to the condition, available information and how well different populations are represented in the training and validation data.

Key Takeaways

  • AI may help your child’s doctors identify patterns across symptoms, medical records, genomic information and some medical images, but it cannot confirm a diagnosis by itself.
  • Your child’s genomic results still require specialist interpretation, and unresolved results may sometimes become useful when they are reanalysed as medical knowledge develops.
  • Research into tools such as PhenoBrain, DeepRare and Eye2Gene is promising, but these systems should support rather than replace specialist clinical judgement.
  • If your child has persistent, unusual or unexplained symptoms, you should seek appropriate medical assessment rather than relying on a public or consumer AI tool.

Frequently Asked Questions

1. Could AI help diagnose your child’s rare disease earlier?
If your child has unusual or unexplained symptoms, you may hear about AI tools that help doctors compare patterns across records, genetic results and other tests. You should know that AI may help narrow the possibilities, but you should still expect specialist assessment and appropriate testing before any diagnosis is confirmed.

2. How can AI help your child’s doctors identify rare diseases?
You may find AI useful because it can compare your child’s combination of symptoms with information from large rare-disease databases. You should treat the result as a shortlist for investigation, and you can ask which suggested conditions actually fit your child’s clinical picture.

3. Can AI analyse your child’s genetic test results?
Yes. You may see AI used to prioritise genetic variants that could match your child’s symptoms and inheritance pattern. You should remember that a highly ranked variant is not automatically the cause, so you still need specialist genetic interpretation before you accept a diagnosis.

4. What happens if AI suggests a diagnosis that your child’s doctors do not agree with?
You should treat the AI suggestion as one possible lead rather than a final answer. Your child’s doctors can compare it with examination findings, family history and test results, and you can ask why they agree or disagree and what you should investigate next.

5. Does every rare disease have an AI diagnostic tool?
No. You should know that different AI systems are built for different types of information or conditions. If you come across a specialised tool such as Eye2Gene, you should not assume its performance applies to every rare disease or to your child’s situation.

6. Is it safe to upload your child’s medical information to a public AI tool?
You should avoid uploading identifiable records, genomic data or photographs to public AI tools unless appropriate privacy, consent and data-security safeguards are in place. If you are unsure, you should ask your child’s healthcare team how your information can be handled safely.

7. What happens if an AI system gives several possible diagnoses?
You may see AI rank several conditions instead of giving one answer. You should expect your child’s specialist team to compare those possibilities with the clinical picture, and you can ask which options are most plausible and what testing you may need next.

8. Can AI make an uncertain genetic variant easier to interpret?
AI may help specialists decide whether an uncertain variant deserves closer attention by comparing it with your child’s symptoms and current evidence. You should still remember that AI cannot turn uncertain evidence into a confirmed diagnosis, so you may need further clinical or genetic evidence.

9. Will AI always shorten the time to a rare disease diagnosis?
No. You may get useful clues more quickly in some cases, but you should know that some diseases remain difficult to diagnose because the responsible gene, variant or mechanism is not yet understood. You may still need specialist review, further testing or future reanalysis.

10. What should you do if you suspect your child has a rare disease?
You should first speak to your child’s paediatrician or another appropriate healthcare professional if you notice persistent, unusual or unexplained symptoms. You can ask whether specialist assessment or genetic, metabolic or neurological testing is appropriate rather than trying to diagnose your child with AI yourself.

Final Thoughts: How AI Could Improve Rare Disease Diagnosis

AI may help doctors recognise patterns in your child’s symptoms, records and genetic results, potentially speeding diagnosis. However, AI remains a support tool, not a replacement for your child’s doctors or clinical judgement.

If you need a trusted paediatrician in London, you can get in touch with our team at London Paediatric Clinic.

References:

  1. Department of Health and Social Care (2026). England Rare Diseases Action Plan 2026: main report. GOV.UK. Published 27 February 2026; updated 14 April 2026.
    https://www.gov.uk/government/publications/england-rare-diseases-action-plan-2026/england-rare-diseases-action-plan-2026-main-report
  2. NHS England (no date). NHS Genomic Medicine Service. NHS England.
    https://www.england.nhs.uk/genomics/
  3. Mao, X., Huang, Y., Jin, Y. et al. (2025). ‘A phenotype-based AI pipeline outperforms human experts in differentially diagnosing rare diseases using EHRs’. npj Digital Medicine, 8, article 68.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11775211/
  4. Zhao, W., Wu, C., Fan, Y. et al. (2026). ‘An agentic system for rare disease diagnosis with traceable reasoning’. Nature, 651(8106), pp. 775-784.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC12999473/
  5. Pontikos, N., Woof, W.A., Lin, S. et al. (2025). ‘Next-generation phenotyping of inherited retinal diseases from multimodal imaging with Eye2Gene’. Nature Machine Intelligence, 7(6), pp. 967-978.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC12185311/
  6. Jaech, A., Cheatham, M., Shringarpure, S.S. et al. (2026). ‘LLM-Assisted Reanalysis of Unsolved Rare Disease Genomes Increases Diagnostic Yield’. NEJM AI, 3(7).
    https://pmc.ncbi.nlm.nih.gov/articles/PMC13417654/
  7. Krawitz, P.M. (2022). ‘Artificial intelligence in the diagnosis of rare disorders: the development of phenotype analysis’. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz, 65(11), pp. 1159-1163.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9636278/